RCM
DNMR

Radcliffe Capital Management’s Danimer Scientific, Inc. DNMR Stock Holding History

Radcliffe Capital Management’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,250
Closed -$490K – 244
2020
Q2 		$490K Buy
+1,250
New +$485K 0.07% 130

Other funds holding DNMR

ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return

Radcliffe Capital Management's DNMR Position: Q4 2020 in Review

Radcliffe Capital Management sold out of Danimer Scientific, Inc. (DNMR) in Q4 2020, closing a stake of 4,444 shares — an estimated $1.79M sold.

Radcliffe Capital Management first reported a position in DNMR in Q2 2020 and held it in 2 quarters. The position peaked at $1.79M in Q3 2020. 77 funds tracked by Wall St. Rank hold DNMR as of Q4 2020.

  • Radcliffe Capital Management reported no remaining Danimer Scientific, Inc. position as of Q4 2020 after selling out during the quarter.
  • Radcliffe Capital Management sold 4,444 Danimer Scientific, Inc. shares in Q4 2020, an estimated $1.79M.
  • Radcliffe Capital Management first reported a position in Danimer Scientific, Inc. in Q2 2020 and held it in 2 quarters.
  • Radcliffe Capital Management's Danimer Scientific, Inc. position peaked at $1.79M in Q3 2020.
  • 77 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2020.

Based on Radcliffe Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.